Page 57 - Malaria News Today

India News: The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Heal.

The World Health Organization has authorized a second malaria vaccine in a decision that could offer countries a cheaper and a more readily available option than the world’s first shot

Oxford University developed the new three-dose vaccine with help from the Serum Institute of India. Research suggests it is more than 75 per cent effective and that protection is maintained for at least another year with a booster. Get more Trending News and Business News on Zee Business.

LONDON (AP) — The World Health Organization authorized a second malaria vaccine on Monday, a decision that could offer countries a cheaper and a more readily available option than the

In this episode of The Conversation Weekly, we hear from the scientists behind a new malaria vaccine developed by the University of Oxford.

An Arkansas resident has contracted malaria, according to the Arkansas Department of Health (ADH).

State officials said a central Arkansas resident has recently contracted a locally acquired case of malaria.

The vaccine developed with researchers at the University of Oxford, known as R21, was recommended Monday by the WHO for use in Africa for children under five years old, the age group and continent that bear the brunt of a disease that kills more than 600,000 people a year.

The World Health Organization (WHO) on Monday recommended a new anti-malaria vaccine for children, a move that could offer countries a cheaper and more readily available option than the worlds first shot against the parasitic disease.

Europe News: GENEVA: The World Health Organization recommended on Monday the use of a second malaria vaccine to curb the life-threatening disease spread to humans .